S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

RPTX Repare Therapeutics Inc

3.48

0.13 (3.88%)

01 Jun 2024 - Closed

Delayed by 15 minutes

Small Cap Massively Bid Following Key Q1 Earnings Beat

A biotech company is turning heads so far during Wednesday’s premarket hours following the company reporting higher than expected revenue and EPS. According to a handful of...

To read the full story on AllPennyStocks.com, click here.

Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Repare Therapeutics Charts.

Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Repare Therapeutics Charts.

Repare Therapeutics Inc News

Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024
Wednesday 29 May 2024 (4 days ago) • Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 25 May 2024 (1 week ago) • Edgar (US Regulatory)

Small Cap Massively Bid Following Key Q1 Earnings Beat
Thursday 9 May 2024 (4 weeks ago) • AllPennyStocks.com

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 8 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
Wednesday 8 May 2024 (4 weeks ago) • Business Wire

Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition
Tuesday 30 April 2024 (1 month ago) • Business Wire

Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors
Saturday 27 April 2024 (1 month ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (3 months ago) • Edgar (US Regulatory)

Repare Therapeutics to Participate in Two Upcoming Investor Conferences
Thursday 29 February 2024 (3 months ago) • Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 29 February 2024 (3 months ago) • Edgar (US Regulatory)

More Repare Therapeutics Inc News Articles

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions